Multi-center evaluation of the fully automated PCR-based Idylla™ KRAS mutation assay for rapid KRAS mutation status determination on formalin-fixed paraffin-embedded tissue of human colorectal cancer
<p>Since the advent of monoclonal antibodies against epidermal growth factor receptor (EGFR) in colorectal cancer therapy, the determination of RAS mutational status is needed for therapeutic decision-making. Most prevalent in colorectal cancer are <em>KRAS</em> exon 2 mutations (4...
Main Authors: | Solassol, J, Vendrell, J, Märkl, B, Haas, C, Bellosillo, B, Montagut, C, Smith, M, O'Sullivan, B, D'Haene, N, Le Mercier, M, Grauslund, M, Melchior, L, Burt, E, Cotter, F, Stieber, D, Schmitt, F, Motta, V, Lauricella, C, Colling, R, Soilleux, E, Fassan, M, Mescoli, C, Collin, C, Pagès, J, Sillekens, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2016
|
Similar Items
-
Clinical Significance of the KRAS Mutation
by: Sead Beganovic
Published: (2010-10-01) -
KRAS mutations and endometriosis burden of disease
by: Natasha L Orr, et al.
Published: (2023-07-01) -
Mutations in the KRAS gene in ovarian tumors.
by: Wiesława Niklińska, et al.
Published: (2009-12-01) -
KRAS mutation in biliary tract cholangiocarcinoma
by: Sora Yasri
Published: (2017-03-01) -
Somatic mutation detection and KRAS amplification in testicular germ cell tumors
by: Eduardo R. M. Cabral, et al.
Published: (2023-03-01)